4-(N-Boc-amino)-1,6-heptanedioic Acid (cas# 848242-88-6) can be used in the preparation of Trastuzumab-linked TLR-agonist-containing conjugates for targeted treatment of cancer. It is also used in the preparation of insulin analog dimers, and composition containing them or an insulin receptor partial agonist and a GLP-1 analog for treating diabetes and related disorders.
滬ICP備17019645號
400-821-0725
